Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05457569

Acceptability and Feasibility of Implementing a Coordinated Hospital/Non-hospital Parenting Support and Prevention Program for Families of Infants at High Neurodevelopmental Risk After Neonatal Intensive Care Hospitalization

Status
Recruiting
Phase
Study type
Observational
Enrollment
88 (estimated)
Sponsor
Centre Hospitalier Universitaire Dijon · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The PRéPaR project aims to construct, with the help of parents and early care providers, a support program for the families of infants at an increased risk for neurodevelopmental disorders, and to evaluate the acceptability and feasibility of such a program. This program aims to strengthen parenting skills, support infant development and improve the continuity of hospital/non-hospital care, including early identification of neurodevelopmental motor disorders and continuation of the support initiated during neonatal hospitalization.

Conditions

Interventions

TypeNameDescription
OTHERFocus group (FC) - WP13 group meetings for each group of parents: 1. Parents only 2. Parents and representatives of patient support groups 3. Parents and health professionals specialized in the care of these children at risk
OTHERChild Neurodevelopment Questionnaires - WP2during the 4th month of corrected infant age
OTHEREvaluation of compliance for the acquired skills in terms of development support - WP2during the 4th month of corrected infant age
OTHEREvaluation of physiotherapist satisfaction with the follow-up and the time spent at the consultation - WP2at the end of the study
OTHER4 Focus Group (FC) - WP2* Parents who accepted the follow-up * Parents who have partially completed the programme * Maternal and Child Protection \& CAMSP professionals * Physiotherapists in a private practice

Timeline

Start date
2023-01-09
Primary completion
2025-11-01
Completion
2025-11-01
First posted
2022-07-14
Last updated
2024-07-22

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05457569. Inclusion in this directory is not an endorsement.